MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration

European Journal of Endocrinology

Volumn 167, Issue 3, 2012, Pages 393-400

  Agretti, Patrizia ^a   Ferrarini, Eleonora ^a   Rago, Teresa ^a   Candelieri, Antonio ^c   De Marco, Giuseppina ^a   Dimida, Antonio ^a   Niccolai, Filippo ^a   Molinaro, Angelo ^a   Di Coscio, Giancarlo ^a,b   Pinchera, Aldo ^a   Vitti, Paolo ^a   Tonacchera, Massimo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 221; MICRORNA 222; MIR 146B; MIR 187; MIR 197; MIR 224; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASPIRATION BIOPSY; BRAF GENE; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; THYROID NODULE;

ADULT; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865704347     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0400     Document Type: Article

References (43)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 281-297. (doi:10.1016/S0092-8674(04)00045-5)
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009 136 215-233. (doi:10.1016/j.cell.2009.01.002)
3. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW & Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005 435 974-978. (doi:10.1038/nature03816)
4. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB & Bartel DP. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 2005 310 1817-1821. (doi:10.1126/science.1121158)
5. Esquela-Kerscher A & Slack FJ. Oncomirs - microRNAs with a role in cancer. Nature Reviews Cancer 2006 6 259-269. (doi:10.1038/nrc1840)
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet- Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR & Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005 435 834-838. (doi:10.1038/nature03702)
7. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC & Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS 2006 103 2257-2261. (doi:10.1073/pnas.0510565103)
8. Hammond SM. MicroRNAs as oncogenes. Current Opinion in Genetics & Development 2006 16 4-9. (doi:10.1016/j.gde.2005.12.005)
9. Hammond SM. MicroRNAs as tumor suppressors. Nature Genetics 2007 39 582-583. (doi:10.1038/ng0507-582)
10. Rosaj J, Carcangiu ML & De Lellis RA. Tumors of the thyroid gland. In Atlas of Tumor Pathology, third series, pp 21-47. Washington, DC: Armed Forces Institute of Pathology (AFIP), 1992.
11. Mazzaferri EM. Management of a solitary thyroid nodule. New England Journal of Medicine 1993 328 553-559. (doi:10.1056/NEJM199302253280807)
12. Tan GH & Gharib H. Thyroid incidentalomas: management approaches to non-palpable nodules discovered incidentally on thyroid imaging. Annals of Internal Medicine 1997 126 226-231.
13. Rago T, Chiovato L, Aghini-Lombardi F, Grasso L, Pinchera A &Vitti P. Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. Journal of Endocrinological Investigation 2001 24 770-776.
14. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi. Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. AACE/AME Task Force on Thyroid Nodules. Endocrine Practice 2006 12 63-102.
15. Gharib H. Fine-needle aspiration biopsy of the thyroid nodules: advantages, limitations and effect. Mayo Clinic Proceedings 1994 69 44-49.
16. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM &de la Chapelle A. The role of microRNA genes in papillary thyroid carcinoma. PNAS 2005 102 19075-19080. (doi:10.1073/pnas.0509603102)
17. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM & Fusco A. MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-Related Cancer 2006 13 497-508. (doi:10.1677/erc.1.01209)
18. Weber F, Teresi RE, Broelsch CE, Frilling A & Eng C. A limited set of human microRNA is deregulated in follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2006 91 3584-3591. (doi:10.1210/jc.2006- 0693)
19. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA & Baloch ZW. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocrine Pathology 2007 18 163-173. (doi:10.1007/s12022-007-0023-7)
20. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ III & Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Modern Pathology: an Official Journal of the United States and Canadian Academy of Pathology, Inc. 2008 21 1139-1146. (doi:10.1038/modpathol. 2008.105)
21. Nikiforova MN, Tseng GC, Steward D, Diorio D & Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. Journal of Clinical Endocrinology and Metabolism 2008 93 1600-1608. (doi:10.1210/jc.2007-2696)
22. Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M & Schmid KW. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. British Journal of Cancer 2010 102 376-382. (doi:10.1038/sj.bjc.6605493)
23. Colamaio M, Borbone E, Russo L, Bianco M, Federico A, Califano D, Chiappetta G, Pallante P, Troncone G, Battista S & Fusco A. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. Journal of Clinical Endocrinology and Metabolism 2011 96 1915-1924. (doi:10.1210/jc.2011-0408)
24. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, Mitrani-Rosenbaum S, Roistacher M, Ariel I, Eid A, Freund HR &Nissan A. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 2011 21 111-118. (doi:10.1089/thy.2010.0356)
25. Shen R, Liyanarachchi S, Li W, Wakely PE Jr, Saji M, Huang J, Nagy R, Farrell T, Ringel MD, de la Chapelle A, Kloos RT & He H. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases. Thyroid 2012 22 9-16. (doi:10.1089/thy.2011.0081)
26. Kitano M, Rahbari R, Patterson EE, Steinberg SM, Prasad NB, Wang Y, Zeiger MA & Kebebew E. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 2012 22 285-291. (doi:10.1089/thy.2011.0313)
27. Rago T, Di Coscio G, Basolo F, Scutari M, Elisei R, Berti P, Micoli P, Romani R, Faviana P, Pinchera A & Vitti P. Combined clinical, thyroid ultrasounds, and cytological features help to predict thyroid malignancy in follicular and Hürtle cell thyroid lesions: results from a series of 505 consecutive patients. Clinical Endocrinology 2006 66 13-20. (doi:10.1111/j.1365- 2265.2006.02677.x)
28. Baloch ZW & LiVolsi VA. Fine needle aspiration of thyroid nodules: past, present and future. Endocrine Practice 2004 10 234-241.
29. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK & Frable WJ. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagnostic Cytopathology 2008 36 425-434. (doi:10.1002/dc.20830)
30. Quinlan JR. Induction of decision trees. Machine Learning 1986 1 81-106.
31. Witten IH & Frank E. Data Mining: Practical Machine Learning Tools and Techniques with Java Implementation 2000. San Francisco: Morgan Kaufmann.
32. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P & Witten IH. The WEKA Data Mining Software: an Update. SIGKDD Explorations 2009 11 10-18.
33. Tonacchera M, Agretti P, Rago T, De Marco G, Niccolai F, Molinaro A, Scutari M, Candelieri A, Conforti D, Musmanno R, Di Coscio G, Basolo F, Iacconi P, Miccoli P, Pinchera A & Vitti P. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency. Journal of Endocrinological Investigation 2011 In press. (doi:10.3275/8012)
34. Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P, Pinchera A & Vitti P. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. European Journal of Endocrinology 2010 162 763-770. (doi:10.1530/EJE-09-0895)
35. Smith J, Cheifetz RE, Schneidereit N, Berean K & Thomson T. Can accurately predict benign follicular nodules? American Journal of Surgery 2005 189 592-595. (doi:10.1016/j.amjsurg.2005.01.028)
36. Carling T & Udelsman R. Follicular neoplasm of the thyroid: what to recommend. Thyroid 2005 15 583-587. (doi:10.1089/thy.2005.15.583)
37. Ferraz C, Eszlinger M & Paschke R. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. Journal of Clinical Endocrinology and Metabolism 2011 96 2016-2026. (doi:10.1210/jc.2010-2567)
38. Nikiforova MN & Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009 19 1351-1361. (doi:10.1089/thy.2009.0240)
39. Lo Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G & Vitale M. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clinical Endocrinology 2007 66 678-683. (doi:10.1111/j.1365-2265.2007.02800.x)
40. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K & Nikiforova MN. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. Journal of Clinical Endocrinology and Metabolism 2009 94 2092-2098. (doi:10.1210/jc.2009-0247)
41. Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F & Mian C. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clinical Chemistry and Laboratory Medicine 2011 49 325-329. (doi:10.1515/cclm.2011.031)
42. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM & Fusco A. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 2007 26 7590-7595. (doi:10.1038/sj.onc.1210564)
43. de la Chapelle A & Jazdzewski K. MicroRNAs in thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2011 96 3326-3336. (doi:10.1210/jc.2011-1004)